February 2024 - Scientific Advisory Appointment

Dr. Smith has been appointed as a scientific advisor to the ALS Network.

January 25th, 2024 - "Misfolded alpha-Synuclein in Amyotrophic Lateral Sclerosis (ALS): Implications for Diagnosis and Treatment" is Available Online

The open access version of "Misfolded alpha-Synuclein in Amyotrophic Lateral Sclerosis (ALS): Implications for Diagnosis and Treatment" has been published in the online library of the European Journal of Neurology and can be accessed here: https://onlinelibrary.wiley.com/doi/10.1111/ene.16206

It will appear in print in an upcoming journal issue.

December 28th, 2023 - "Misfolded alpha-Synuclein in Amyotrophic Lateral Sclerosis (ALS): Implications for Diagnosis and Treatment" Accepted for Publication in the European Journal of Neurology

Research spearheaded by the Center and Amprion Pharmaceutical identified a sub-group of sporadic ALS patients in whom a self-replicating protein was detected in spinal fluid. The implication of this finding for the treatment of patients will be the focus of the Center's research.